Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Public Health ; 127(8): 761-5, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23876300

ABSTRACT

OBJECTIVES: While there is extensive evidence about the influence of environmental factors on adult obesity, fewer studies have assessed how the environment influences body fat in children. This cross-sectional study investigated the distribution of adiposity indices according to urbanization level and patterns of physical activity among children in the Italian cohort of the IDEFICS study. METHODS: The sample included 1673 preschool and school-aged children (mean age 6.1 years, standard deviation 1.7) living in rural (n = 579), suburban (n = 442) and urban (n = 652) areas. Anthropometric measures were taken and questionnaires were used to assess children's lifestyles, including patterns of physical activity. RESULTS: Children who lived in rural areas spent significantly more time in outdoor activities but participated in less structured physical activity compared with children living in suburban and urban areas. Adiposity estimated by the sum of skinfold thickness increased linearly from rural to urban areas, with results for suburban areas showing intermediate values. CONCLUSIONS: The data show that geographical environmental factors influence patterns of physical activity and body fat in children. In particular, the results suggest an association between the time spent in unstructured outdoor activities and the degree of adiposity in schoolchildren. These results may have implications for public health, including efforts to increase freely available playgrounds as an effective measure to counteract the obesity epidemic in children.


Subject(s)
Adiposity , Motor Activity , Pediatric Obesity/epidemiology , Rural Health/statistics & numerical data , Urban Health/statistics & numerical data , Urbanization , Child , Child, Preschool , Cross-Sectional Studies , Female , Humans , Italy/epidemiology , Male , Skinfold Thickness , Surveys and Questionnaires
2.
Int J Obes (Lond) ; 37(7): 914-9, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23567926

ABSTRACT

OBJECTIVE: To investigate the association between gestational weight gain (GWG) and total adiposity, body fat distribution, blood pressure (BP), and metabolic profile in offspring. DESIGN: Cross-sectional study. METHODS: Body mass index (BMI), waist, subscapular and tricipital skinfolds, and BP were measured and blood samples drawn in 12 775 children (aged 2-9 years) from the IDEFICS cohort. Overweight/obesity was defined by IOTF criteria. Parents filled in a questionnaire investigating child and familiar medical history and lifestyle. A section was dedicated to pregnancy history (including GWG). RESULTS: Anthropometric indices linearly and significantly increased across GWG tertiles (BMI z-score: tertile I =0.08, 0.03-0.13; tertile II =0.16, 0.12-0.21; tertile III =0.34, 0.28-0.40, P<0.01, mean, 95% CI) by analysis of covariance (ANCOVA) adjusted by child sex, age and practice of sport, birth weight, current maternal BMI, parental education, gestational age, age at delivery, alcohol and smoking during pregnancy, maternal diabetes mellitus, gestational hypertension, and breastfeeding duration. After inclusion of BMI z-score among covariates, HbA1c significantly increased across tertiles (P=0.009) while no differences were observed for BP, serum insulin, HOMA index, blood glucose and lipids. The adjusted risk of overweight/obesity significantly increased by 14 and 22% in tertiles II and III respectively, in comparison with tertile I by logistic regression analysis controlling for covariates. CONCLUSION: Maternal GWG is an independent predictor of total adiposity and body fat distribution in offspring during infancy. Exposure to perinatal factors should be taken into account for early prevention of overweight and obesity.


Subject(s)
Adiposity , Blood Pressure , Body Fat Distribution , Metabolome , Obesity, Abdominal/prevention & control , Pregnancy Complications/prevention & control , Weight Gain , Age of Onset , Birth Weight , Body Composition , Body Mass Index , Child , Child, Preschool , Cross-Sectional Studies , Europe , Female , Gestational Age , Glycated Hemoglobin/metabolism , Humans , Male , Mothers , Obesity, Abdominal/epidemiology , Obesity, Abdominal/etiology , Pregnancy , Pregnancy Complications/epidemiology , Pregnancy Complications/etiology , Prenatal Exposure Delayed Effects , Retrospective Studies , Risk Factors , Skinfold Thickness , Surveys and Questionnaires
3.
J Interferon Cytokine Res ; 21(7): 469-70, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11506739

ABSTRACT

We describe the case of a 56-year-old man who had high aminotransferase levels and anti-hepatitis C virus (HCV) antibodies. He underwent liver biopsy and biochemical screening to evaluate whether he would benefit from interferon (IFN) treatment. The patient was discharged with a diagnosis of HCV-related active chronic hepatitis, skin porphyria, and type 2 diabetes. On December 5, 1995, he began therapy with recombinant IFN-alpha at a dose of 3 MIU three times a week. He stopped this therapy in February 1996 because of asthenia, diplopia, headache, and anxiety. During IFN therapy, he had normal aminotransferase levels and no detectable HCV RNA, a condition that persists to the present. Between March and May 1996, the patient was admitted several times to a neurology clinic, where myasthenia gravis was diagnosed and treatment with pyridostigmine and cyclosporine was initiated. This case and others indicate that caution should be exercised in administering IFN because low doses can be correlated with myasthenia gravis in patients without malignancies.


Subject(s)
Hepatitis C, Chronic/drug therapy , Interferon Type I/adverse effects , Interferon Type I/therapeutic use , Myasthenia Gravis/chemically induced , Antiviral Agents/administration & dosage , Antiviral Agents/adverse effects , Antiviral Agents/therapeutic use , Drug Administration Schedule , Hepatitis C, Chronic/diagnosis , Hepatitis C, Chronic/enzymology , Humans , Interferon Type I/administration & dosage , Male , Middle Aged , Myasthenia Gravis/diagnosis , Myasthenia Gravis/drug therapy , Recombinant Proteins
4.
Infection ; 28(2): 119-20, 2000.
Article in English | MEDLINE | ID: mdl-10782401

ABSTRACT

We describe long-term therapy for paracoccidioidomycosis occurring in a 61-year-old house-painter from Venezuela. The diagnostic examinations made in South America had shown pulmonary granulomatous lesions and an osteolytic pattern of the left knee that had been considered suspect of malignant disease with an indication for limb amputation. With the aid of fine needle aspiration biopsy (FNAB) and culture examination we diagnosed an osteomyelitis by Paracoccidioides brasiliensis and initiated therapy with itraconazole, 400 mg per day, reduced to 200 mg per day after 2 months. At the end of 2 years of drug therapy, we observed complete regression of the pulmonary lesions and of the osteolytic area of the left knee. Moreover, we have periodically observed our patient to verify his clinical development and he is still in good health. We suggest that this pathology be considered in differential diagnosis of leprosy, tuberculosis, leishmaniasis, and systemic mycoses, even in non-endemic areas.


Subject(s)
Antifungal Agents/administration & dosage , Itraconazole/administration & dosage , Osteomyelitis/drug therapy , Paracoccidioides/isolation & purification , Paracoccidioidomycosis/drug therapy , Biopsy, Needle , Drug Administration Schedule , Humans , Knee Joint , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...